2012
DOI: 10.1159/000339817
|View full text |Cite
|
Sign up to set email alerts
|

Functional TSH Receptors, Malignant Melanomas and Subclinical Hypothyroidism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 3 publications
0
7
0
Order By: Relevance
“…( 169 ); Figures 3 J,K]. Recently, the hippocampus of developmentally hypothyroid pups showed altered VGluT1/VGAT immunoreactivity ( 180 ). Although Camk4/Creb pathway plays a fundamental role in neurites growth and establishment of synapses, other genes are involved in the development of hippocampal connections.…”
Section: Alterations In Cortical Development Caused By Thyroid Hormonmentioning
confidence: 99%
See 2 more Smart Citations
“…( 169 ); Figures 3 J,K]. Recently, the hippocampus of developmentally hypothyroid pups showed altered VGluT1/VGAT immunoreactivity ( 180 ). Although Camk4/Creb pathway plays a fundamental role in neurites growth and establishment of synapses, other genes are involved in the development of hippocampal connections.…”
Section: Alterations In Cortical Development Caused By Thyroid Hormonmentioning
confidence: 99%
“…In agreement, GAP-43 −/− mice failed to express 5-HTT in the barrel cortex causing a disrupted segregation of thalamic afferents in the barrel cortex. In addition, recent data show that the density of VGluT1-immunoreactive buttons is decreased in layer IV of the parietal cortex of hypothyroid rats ( 180 ). These data show that there is an asynchrony in the maturation of thalamocortical afferents and their cortical targets in hypothyroid rats.…”
Section: Alterations In Cortical Development Caused By Thyroid Hormonmentioning
confidence: 99%
See 1 more Smart Citation
“…Shortly thereafter, the same group found that melanocyte-originated lesions ranging from a benign nevus, dysplastic nevi, and melanoma all express functional TSHR, with an upregulated expression in premalignant and malignant lesions, implying a higher sensitivity to TSH [48]. Combining this with the study that found TSH can promote the growth of melanoma by triggering the formation of cAMP and activating the mitogen-activated protein kinase (MAPK) signaling pathway, may in part account for the high prevalence of hypothyroidism (elevated TSH lever) in the melanoma population [48,49]. Intriguingly, another study has reported that suppression of MAP kinase and PI3KAkt pathways exhibits their anti-melanoma effects, including suppression of cell proliferation, transformation, and invasion, and these effects are coupled with inducing the expression of thyroid genes, such as TSH-R and NIS, and consequently increasing radioiodide uptake by melanoma cells, which may prove to be a novel approach to treating melanoma [50,51].…”
Section: Hypothalamic-pituitary-thyroid Axis (Hpt) Homologmentioning
confidence: 95%
“…Indeed, TSH has been recognized as a tumor promoting factor not only for DTC, but even for other ETM such as ovarian cancer and hepatocellular carcinoma [ 106 ]. TSH receptor (TSHR) expression, at both mRNA and protein level, has been documented in skin tissues and different skin cell types including cultured keratinocytes, dermal fibroblasts, epidermal melanocytes, and melanoma cells [ 102 , 107 , 108 , 109 , 110 ]. In particular, Ellerhorst and colleagues detected the TSHR in all cutaneous melanocytic lesions, namely benign nevi, dysplastic nevi, and melanomas [ 109 ].…”
Section: Hormonal Players Of the Hypothalamic–pituitary–thyroid Axis ...mentioning
confidence: 99%